Clinical Development Committee

The Clinical Development Committee is a new committee that started its activities in April 2022.

Based on the current changes in the environment surrounding clinical development of pharmaceuticals , the main themes of the committee are: 1) Utilization of RWD/RWE in new drug approval review, 2) GCP Renovation, and 3) Development of programmed medical devices.

We will disseminate the results of our discussions through monthly meetings and theme-specific WG activities in academic symposia, educational seminars, published papers, etc.